Characterization of tropane alkaloid aromatic esters that reverse the multidrug-resistance phenotype

Anticancer Research

Volumn 22, Issue 3, 2002, Pages 1385-1398

  Mi, Qiuwen ^a   Cui, Baoliang ^a   Chávez, Daniel ^a   Chai, Heebyung ^a   Zhu, Haiyuan ^a   Cordell, Geoffrey A ^a   Hedayat, Sam ^a   Kinghorn, A Douglas ^a   Pezzuto, John M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Aromatic tropane alkaloid esters; Cancer chemotherapy; MDR1 gene; Multidrug resistance; Verapamil

Indexed keywords

3ALPHA (3,4,5 TRIMETHOXYBENZOYLOXY) 6BETA (3,4,5 TRIMETHOXYCINNAMOYLOXY) 7BETA HYDROXYTROPANE; 3ALPHA (3,4,5 TRIMETHOXYBENZOYLOXY) 6BETA (3,4,5 TRIMETHOXYCINNAMOYLOXY)TROPANE; 3ALPHA PHENYLACETOXY 6BETA (3,4,5 TRIMETHOXYCINNAMOYLOXY)TROPANE; 3ALPHA,6BETA BIS(3,4,5 TRIMETHOXYCINNAMOYLOXY) 7BETA HYDROXYTROPANE; 3ALPHA,6BETA BIS(3,4,5 TRIMETHOXYCINNAMOYLOXY)TROPANE; GLYCOPROTEIN P; TROPANE ALKALOID; UNCLASSIFIED DRUG; VINBLASTINE;

ARTICLE; BIOASSAY; CELL GROWTH; CONFOCAL MICROSCOPY; DRUG STRUCTURE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

DRUG RESISTANCE, MULTIPLE; DRUG SYNERGISM; ERYTHROXYLACEAE; ESTERS; GROWTH INHIBITORS; HUMANS; KB CELLS; LEUKEMIA, LYMPHOCYTIC; MICROSCOPY, CONFOCAL; PLANT EXTRACTS; RHODAMINE 123; STRUCTURE-ACTIVITY RELATIONSHIP; TROPANES; VINBLASTINE;

EID: 0036330570     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Biochemistry of multidrug resistance mediated by the multidrug transporter
2. Inhibitors of multidrug resistance
3. In vivo model systems in P-glycoprotein-mediated multidrug resistance
4. Pharmacology of drugs that alter multidrug resistance in cancer
5. The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans
6. Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo
7. Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance
8. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY 335979
9. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells
10. New multidrug-resistance-reversing drugs, MS-209 and SDZ PSC 833
11. S9788 modulation of P-glycoprotein and multidrug-related protein-mediated multidrug resistance by Servier 9788 in doxorubicin-resistant MCF-7 cells
12. In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative
13. Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blockers
14. Cure of mice bearing P388 leukemia by vincristine in combination with a calcium channel blocker
15. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52
16. Enhancement of antitumour activity of etoposide by dihydropyridines on drug-sensitive and drug-resistant leukemia in mice
17. In vivo reversal of multidrug resistance by two new dihydropyridine derivatives, S16317 and S16324
18. Discovery and development of antineoplastic agents from natural sources
19. Novel strategies for the discovery of plant-derived anticancer agents
20. Indole alkaloids from Peschiera laeta that enhance vinblastine-mediated cytotoxicity with multidrug-resistant cells
21. Roemerine, an aporphine alkaloid from Annona senegalensis that reverses the multidrug-resistance phenotype with cultured cells
22. Modulation of the multidrug-resistance phenotype by new tropane alkaloid aromatic esters Erythroxylum pervillei
23. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype
24. Reversal of multidrug resistance by tropane alkaloids from the stems of Erythroxylum rotundifolium
25. Selective toxicity of rhodamine 123 in carcinoma cells in vitro
26. Localization of mitochondria in living cells with rhodamine 123
27. Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine 123 in human tumors
28. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells
29. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen
30. Use of fluorescent dyes as molecular probes for the study of multidrug resistance
31. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells
32. Sensitizing properties of new N-(2-arylalkyl)propionamides in drug-sensitive and multidrug-resistant tumor cells
33. Physicochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum
34. Membrane permeation by multidrug-resistance-modulators and non-modulators: Effects of hydrophobicity and electric charge
35. Molecular modeling of phenothiazines and related drugs as multidrug resistance modifiers: A comparative molecular field analysis study
36. Synthesis and in vitro multidrug resistance modulating activity of a series of dihydrobenzopyrans and tetrahydroquinolines
37. A combined Hansch/Free-Wilson approach as predictive tool in QSAR studies on propafenone-type modulators of multidrug resistance
38. Reversal of vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil
39. Altered surface membrane glycoproteins in vinca alkaloid-resistant human leukemic lymphoblasts
40. MDR-1 gene expression is a minor factor in determining the multidrug resistance phenotype of MCF7/ADR and KB-V1 cells
41. The overall partitioning of anthracyclines into phosphatidyl-containing model membranes depends neither on the drug charge nor the presence of anionic phospholipids
42. P-Glycoprotein-mediated Hoechst 33342 transport out of the lipid bilayer
43. Steroid treatment, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells
44. Overcoming of vinblastine resistance by isoquinolinesulfonamide compounds in adriamycin-resistant leukemia cells
45. Effect of newly synthesized indole derivatives on multidrug resistance in human cancer cells
46. Differential effects of estrogen, tamoxifen and the pure antiestrogen ICI 182,780 in human drug-resistant leukemia cell lines
47. Chemical specificity of the PDR5 multidrug resistance gene product of Saccharomyces cerevisiae based on studies with tri-n-alkyltin chlorides
48. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells